4543 — Terumo Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Terumo, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	628,897	613,842	703,303	820,209	921,863
Cost of Revenue
Gross Profit	343,933	326,623	369,341	417,370	479,175
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	518,286	515,456	587,343	702,877	781,767
Operating Profit	110,611	98,386	115,960	117,332	140,096
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	106,466	97,060	114,501	116,137	140,829
Provision for Income Taxes
Net Income After Taxes	85,038	77,201	88,814	89,326	106,374
Minority Interest
Net Income Before Extraordinary Items
Net Income	85,211	77,268	88,814	89,326	106,374
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	85,250	77,272	88,813	89,325	106,374
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	55.2	50.6	59	60.7	71.5
Dividends per Share